Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28394174 | 1.00 | TDP1 (0.67) | TDP1 | |
| Ethylene SCHEMBL8575909 | 0.93 | TDP1 (0.57) | TDP1 | |
| SCHEMBL16910012 | 0.85 | TDP1 (0.57) | TDP1 | |
| Methyl Alcohol SCHEMBL2170375 | 0.82 | — | — | |
| Hydrogen Peroxide SCHEMBL135017 | 0.82 | TDP1 (0.80) | TDP1 | |
| Hydrogen Peroxide SCHEMBL135019 | 0.82 | — | — | |
| SCHEMBL1332279 | 0.82 | — | — | |
| SCHEMBL2020 | 0.82 | — | — | |
| Methyl Alcohol SCHEMBL21933067 | 0.78 | TDP1 (0.73) | TDP1 | |
| Isopropyl Alcohol SCHEMBL11224772 | 0.78 | TDP1 (0.73) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117651707-A | Novel synthetic TLR4 receptor agonists | 米兰-比可卡大学 | 2024-03-05 | — | — | CN | claimed |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4331617-A1 | ARTIFICIAL NUCLEIC ACID AND NUCLEIC ACID DELIVERING METHOD USING SAME | Japan Science and Technology Agency (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117651707-A | Novel synthetic TLR4 receptor agonists | 米兰-比可卡大学 | 2024-03-05 | — | — | CN | disclosed |
| CN-115485384-A | Modified short interfering nucleic acid (siNA) molecules and uses thereof | 阿利戈斯治疗公司 | 2022-12-16 | — | — | CN | disclosed |
| EP-2260936-B1 | Method for specifically located synthesis of nucleic acids on solid carriers | CLONDIAG GMBH (DE) | 2017-12-27 | — | — | EP | disclosed |
| US-20110160082-A1 | Mobility-Modified Nucleobase Polymers and Methods of Using Same | Life Technologies Corporation (US) | 2011-06-30 | — | — | US | disclosed |
| US-7897338-B2 | Mobility-modified nucleobase polymers and methods of using same | APPLIED BIOSYSTEMS, LLC (US) | 2011-03-01 | — | — | US | disclosed |
| EP-1814656-B1 | METHOD FOR SPECIFICALLY LOCATED SYNTHESIS OF BIOPOLYMERS ON SOLID CARRIERS | CLONDIAG GMBH (DE) | 2011-01-05 | — | — | EP | disclosed |
| EP-2260936-A2 | Method for specifically located synthesis of biopolymers on solid carriers | CLONDIAG GmbH (DE) | 2010-12-15 | — | — | EP | disclosed |
| EP-1084134-A4 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS INC (US) | 2004-05-26 | — | — | EP | disclosed |
| EP-1379698-A1 | MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME | Applera Corporation (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20030153743-A1 | Processes for the synthesis of oligomeric compounds | MANOHARAN MUTHIAH (US) | 2003-08-14 | — | — | US | disclosed |
| US-6531590-B1 | Having bioreversible phosphate blocking groups, using a phosphoramite reactant carrying the phosphate blocking group; designed for cleavage by carboxyesterases to yield unprotected oligonucleotides | ISIS PHARMACEUTICALS, INC. | 2003-03-11 | — | — | US | disclosed |
| US-20020182602-A1 | Mobility-modified nucleobase polymers and methods of using same | APPLIED BIOSYSTEMS, INC. | 2002-12-05 | — | — | US | disclosed |
| WO-2002083954-A1 | MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME | APPLERA CORPORATION (US) | 2002-10-24 | — | — | WO | disclosed |
| EP-1084134-A1 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999064434-A1 | SYNTHETIC METHODS AND INTERMEDIATES FOR TRIESTER OLIGONUCLEOTIDES | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1999062922-A1 | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999055717-A1 | PROCESSES FOR THE SYNTHESIS OF OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1999-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020182602-A1 | Mobility-modified nucleobase polymers and methods of using same | PCNA, PNKP, SAMHD1 | TDP1 147/4885 |
| US-20030153743-A1 | Processes for the synthesis of oligomeric compounds | PPIP5K2, NUDT21, NUDT1 | TDP1 282/4885 |
| US-20240238325-A1 | Artificial Nucleic Acid and Method for Delivery of Nucleic Acid Using the Same | HNRNPH3, RNASEH1, HNRNPA1 | TDP1 520/4885 |
| US-20110160082-A1 | Mobility-Modified Nucleobase Polymers and Methods of Using Same | PCNA, PNKP, SAMHD1 | TDP1 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.